19th Pharmacovigilance 2019
ID: 95994

19th Pharmacovigilance 2019

Thu 25th Jul 2019 - Thu 10th Oct 2019 03:51 PM - 06:00 PM DoubleTree Suites by Hilton Hotel Boston - Cambridge, Boston
This event has ended, click here to view upcoming events from Virtue Insight

19th Pharmacovigilance 2019


19th Pharmacovigilance 2019

“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management"

08th - 10th October 2019, Hotel TBC, Cambridge, Boston, USA

19th Pharmacovigilance 2019 will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.  The entire program will cover the detection, analysis and prevention of adverse drug reactions.  It will be studied with the help of case studies and industry experiences.  Hence, this conference will provide an important platform for pharmacovigilance stakeholders to discuss and share best practices in expediting Pv development. 


  • GOLD SPONSOR: Brookwood, AB Cube, AWINSA Life Sciences 
  • BRONZE SPONSOR: 4C Pharma Solutions


  • DEREK ROY, Resident Agent in Charge, FDA
  • BRUNO MENDEZ, VP Global Quality Head Pharmacovigilance, Sanofi
  • MARIETTE BOERSTOEL-STREEFLAND, Sr. VP PharmacoVigilance & Drug Safety, Alexion Pharmaceuticals
  • COLLEEN WALSH, Senior Director, Pharmacovigilance & Regulatory Quality Management Operations, Alexion Pharmaceuticals
  • GERSON PELTZ, Senior Director - Oncology Safety Risk Lead, Pfizer
  • SANDRA RAFF, Senior Director, Global Drug Safety and Risk Management, Takeda Pharmaceuticals
  • BRUCE DONZANTI, Senior Group Director, Regulatory Pharmacovigilance Policy, Genentech
  • WILLIAM WANG, Executive Director, Clinical Safety Statistics, Merck
  • MELVIN MUNSAKA, Senior Director, Head Safety Statistics, Abbvie
  • XIAO NI, Director, Scientific Computing and Consulting, Novartis
  • SHARON REID, Director, Risk Management Product Lead, Pfizer
  • WILLIAM BLUMENTALS, Sr. Director, Head of Pharmacoepidemiology, Sanofi Genzyme
  • ANNAYA BHATTACHARYA, Global Lead for Safety & Risk Management, Bristol-Myers Squibb
  • HARISHA KADALI, Associate Medical Director, Takeda Pharmaceuticals
  • JAYLAXMI NALAWADE, Associate Director - Pharmacovigilance and REMS, Lupin
  • RICHARD WOLF, Executive Director, Pv Operations, CSL Behring
  • PHIL TREGUNNO, Group Manager - Vigilance, Intelligence and Research Group, MHRA (UK)
  • STEINAR MADSEN, Medical Director, Norwegian Medicines Agency (UK)
  • HEATHER LEIGH FLANNERY, Global Lead, ConsenSys Health
  • TOYIN ADEWOLE, Associate Director, Drug Safety - Clinical Research, Supernus Pharmaceuticals
  • SANJEEV MIGLANI, Founder and Director, AWINSA Life Sciences
  • MUGDHA CHOPRA, Cofounder & Director, AWINSA Life Sciences
  • KEVIN TYNAN, Consultant, Global Clinical Safety and Pharmacovigilance, CSL Behring
  • ISRAEL GUTIERREZ, VP Pharmacovigilance & Drug Safety, Geron Corporation
  • SHEETAL KHEDAR, Senior Director, Regulatory Science, Sarah Cannon Development Innovations
  • DAVID HUTCHINSON, Founder,Brookwood International Academy
  • MELVA COVINGTON, Senior Principal, AGAPE Strategic Solutions
  • BEN LOCWIN, Senior Vice President, Quality, Lumicell

Plus many more


  • Pharmacovigilance in the US: What comes next for the industry?
  • Recent developments - legislation, policies, systems, technology, communication strategies and best practice in PV
  • Challenges and Opportunities for Effective Pharmacovigilance in the 21st Century 
  • Why does pharmacovigilance sometimes fail and where
could the fault lie?
  • Pharmacovigilance and healthcare system
  • Future of Signal Detection - Growing companies and safety efficiencies
  • Technology Impact - Cloud – Big data – Analytics – AI – Machine learning
  • Good Clinical Practices and Good Pharmacovigilance practices
  • Future of outsourced phase I, II and III trials and post-marketing studies, 
  • Data quality management and analysis – analyzing the new guidelines
  • Strategies to improve clinical trials and PV
  • Maintaining proper balance in relationships: Sponsor – Site – CRO & Patients
  • Patient centric approach to help improve patient safety
  • Outsourcing activities - Choosing your right vendor and setting the path right
  • PV Audit & inspections - preparation, implementation and lessons to be learnt
  • Discover approaches for collecting, integrating and analyzing all of the safety data generated from preclinical models
  • Current regulations and guidelines - USA, EU and RoW
  • The developing regulatory framework in advanced and developing markets 
  • Be part of a major networking opportunity


CEO’s, CTO’s, CIO’s, Presidents, VPs, Directors, Heads, Managers, Scientific Advisors, Consultants of:

Pharmacovigilance, Pharmacoepidemiology, Pharmacogenomics, Drug/Product Safety, Drug Development, Information and Clinical Data Management, Clinical Pharmacology, Clinical Safety, Periodical safety update Reports, Risk Management, Research & Development, Quality Assurance, Patient Safety, Signal Detection, Safety Surveillance, Outcomes Research, Data Analysis, Epidemiology, Medical Affairs, Regulatory Affairs and Compliance, Information technology, Sales and Marketing 


 E-mail - kavitha@virtueinsight.co.in  or Tel: +44 2036120886

 Sponsor, Exhibition Stall (Booth) and a paid Speaker Slots are also available.

 We also have some sponsorship opportunities available for the event, which gives you an opportunity to sponsor/speak/exhibit, and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts. 


In order to register contact us on Email: kavitha@virtueinsight.co.in  Tel: +44 2036120886

Conference Only:

  • Introductory Offer (3 delegate places for the price of 2) A huge saving(Limited seats left)
  • Early Discount (25th June 2019 - 19th August 2019): (£1299 per delegate)
  • Standard Registration (20th August 2019 Onwards): (£1499 per delegate)

Conference + Workshop:

  • Introductory Offer (3 delegate places for the price of 2) A huge saving - (Limited seats left) 
  • Early Discount (25th June 2019 - 19th August 201): (£1499 per delegate)
  • Standard Registration (20th August 2019 Onwards): (£1699 per delegate)

Workshop Oniy - £399

Whether you are on the branded or generic side, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway.  Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry, research and development costs, and regulatory hurdles, which are balanced against an enormous potential for increased profit margins. Expand your knowledge of the latest business models and strategies in the high-level conference.

19th Pharmacovigilance 2019
DoubleTree Suites by Hilton Hotel Boston - Cambridge, 400 Soldiers Field Rd, Boston, MA 02134, USA,
Boston, Massachusetts, United States (get direction)
Added By

Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical indu Read more

Customer Questions & Answers
Have a Discount Code?
Coupon code applied  clear
Amount Payable
0(including all taxes)